PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Cancers · 26.05.2023 · 15 (11) · 2923
DOI: 10.3390/cancers15112923 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.05.2023. Verfasst von Leonardo Mercanti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca (MUR), the Ministero dell’Università e della Ricerca (MUR).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is among the leading causes of death by cancer in the world. What makes this pathological condition particularly lethal is a combination of clinical and molecular heterogeneity, lack of early diagnostic indexes, and underwhelming results from current therapeutic protocols. A major cause of PDAC chemoresistance seems to lie in the ability of cancer cells to spread out and fill the pancreatic parenchyma, exchanging nutrients, substrates, and even genetic material with cells from the surrounding tumor microenvironment (TME). Several components can be found in the TME ultrastructure, including collagen fibers, cancer-associated fibroblasts, macrophages, neutrophils, mast cells, and lymphocytes. Cross-talk between PDAC and TME cells results in the latter being converted into cancer-favoring phenotypes; this behavior could be compared to an influencer guiding followers into supporting his activity. Moreover, TME could be a potential target for some of the newest therapeutic strategies; these include the use of pegvorhyaluronidase-α and CAR-T lymphocytes against HER2, FAP, CEA, MLSN, PSCA, and CD133. Other experimental therapy options are being currently studied, aiming to interfere with the KRAS pathway, DNA-repairing proteins, and apoptosis resistance in PDAC cells. Hopefully these new approaches will grant better clinical outcomes in future patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.
- Campus Bio-Medico University of Rome, 00128 Roma, Italy.
ORCID-Profile: Mariangela Mazzone, Maria Carmela Di Marcantonio
Förderung
- Ministero dell'Università e della Ricerca (MUR)
- the Ministero dell’Università e della Ricerca (MUR)
Zitieren
APA
Mercanti, L., Sindaco, M., Mazzone, M., Di Marcantonio, M. C., Piscione, M., Muraro, R., & Mincione, G. (2023). PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers, 15(11), 2923. https://doi.org/10.3390/cancers15112923
Vancouver
Mercanti L, Sindaco M, Mazzone M, Di Marcantonio MC, Piscione M, Muraro R, et al. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers. 2023;15(11):2923. doi:10.3390/cancers15112923
BibTeX
@article{Mercanti2023,
author = {Mercanti, Leonardo and Sindaco, Maria and Mazzone, Mariangela and Di Marcantonio, Maria Carmela and Piscione, Mariagrazia and Muraro, Raffaella and Mincione, Gabriella},
title = {PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies},
journal = {Cancers},
year = {2023},
volume = {15},
number = {11},
pages = {2923},
doi = {10.3390/cancers15112923}
}
EUVIMED